F-star Biotechnology Competitors and Similar CompaniesClear all
F-star Biotechnology's competitors and similar companies include Aceragen.
 F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. |  Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. | |
Founding Date | Founding Date 2006 | Founding Date 1989 |
Type | Type Private | Type Public |
Tags | ||
Locations | Locations Cambridge, GB HQ Wien, AT Cambridge, US | Locations Durham, US HQ |
Employees | Employees 39 | Employees 3642% decrease |
Financial | ||
Revenue (est.) | Revenue (est.) £18.7m (FY, 2018) | Revenue (est.) $4.9m (FY, 2022) |
Net income | Net income (£2.6m) (FY, 2018) | Net income ($23.4m) (FY, 2022) |
Funding | ||
Total funding raised | Total funding raised $ 57.3m | Total funding raised $ 13.8m |
For sources of this data, please see the company profile
View Company Profiles
Aceragen
HQ
Durham, US
Employees
36↓ 42% decrease
Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates.
View company